Transaction Details

Footnotes

The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted on August 11, 2025. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted on August 11, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.96 to $15.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.92 to $15.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | The stock option award was granted to the Reporting Person on December 7, 2021, and initially represented a right to purchase a total of 420,881 shares upon vesting. 1/12 of the shares subject to the stock option vested on December 3, 2022, and 1/12 of the shares vested or will vest quarterly thereafter.